CLYDPharmaceutical PreparationsFiscal year ends December 31
BEACON TOPCO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 14, 2026
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Beacon Topco statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Balance sheet
| Measure | Beacon Topco | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $0 | $61.43M |
| Net Cash (Debt) | $0 | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
Shares
| Measure | Beacon Topco | Industry median |
|---|---|---|
| Shares Outstanding | 100 | 58,127,000 |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 100 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
Calculated by StockData from Beacon Topco's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.